BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 34970226)

  • 1. Analysis of Related Factors of Tumor Recurrence or Progression After Transnasal Sphenoidal Surgical Treatment of Large and Giant Pituitary Adenomas and Establish a Nomogram to Predict Tumor Prognosis.
    Chen Y; Cai F; Cao J; Gao F; Lv Y; Tang Y; Zhang A; Yan W; Wang Y; Hu X; Chen S; Dong X; Zhang J; Wu Q
    Front Endocrinol (Lausanne); 2021; 12():793337. PubMed ID: 34970226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transsphenoidal Surgery of Giant Pituitary Adenoma: Results and Experience of 239 Cases in A Single Center.
    Chen Y; Xu X; Cao J; Jie Y; Wang L; Cai F; Chen S; Yan W; Hong Y; Zhang J; Wu Q
    Front Endocrinol (Lausanne); 2022; 13():879702. PubMed ID: 35600598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large and giant pituitary adenoma resection by microscopic trans-sphenoidal surgery: Surgical outcomes and complications in 123 consecutive patients.
    Karki M; Sun J; Yadav CP; Zhao B
    J Clin Neurosci; 2017 Oct; 44():310-314. PubMed ID: 28778803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection.
    Juraschka K; Khan OH; Godoy BL; Monsalves E; Kilian A; Krischek B; Ghare A; Vescan A; Gentili F; Zadeh G
    J Neurosurg; 2014 Jul; 121(1):75-83. PubMed ID: 24785323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
    Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
    J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Pathologic Characteristics Predicted the Postoperative Recurrence and Progression of Pituitary Adenoma: A Retrospective Study with 10 Years Follow-Up.
    Lv L; Yin S; Zhou P; Hu Y; Chen C; Ma W; Jiang Y; Wang Z; Jiang S
    World Neurosurg; 2018 Oct; 118():e428-e435. PubMed ID: 29981466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic endonasal surgery for giant pituitary adenomas: advantages and limitations.
    Koutourousiou M; Gardner PA; Fernandez-Miranda JC; Paluzzi A; Wang EW; Snyderman CH
    J Neurosurg; 2013 Mar; 118(3):621-31. PubMed ID: 23289816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical pituitary adenoma: a clinicopathologic case series.
    Rutkowski MJ; Alward RM; Chen R; Wagner J; Jahangiri A; Southwell DG; Kunwar S; Blevins L; Lee H; Aghi MK
    J Neurosurg; 2018 Apr; 128(4):1058-1065. PubMed ID: 28598278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Endoscopic Transnasal Transsphenoidal Surgery for Giant Pituitary Adenoma.
    Kuo CH; Yen YS; Wu JC; Chang PY; Chang HK; Tu TH; Huang WC; Cheng H
    World Neurosurg; 2016 Jul; 91():121-8. PubMed ID: 27060516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten years' experience with intraoperative MRI-assisted transsphenoidal pituitary surgery.
    Hlaváč M; Knoll A; Mayer B; Braun M; Karpel-Massler G; Etzrodt-Walter G; Coburger J; Wirtz CR; Paľa A
    Neurosurg Focus; 2020 Jun; 48(6):E14. PubMed ID: 32480376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results and risk factors for recurrence following endoscopic endonasal transsphenoidal surgery for pituitary adenoma.
    Bodhinayake I; Ottenhausen M; Mooney MA; Kesavabhotla K; Christos P; Schwarz JT; Boockvar JA
    Clin Neurol Neurosurg; 2014 Apr; 119():75-9. PubMed ID: 24635930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients.
    Del Basso De Caro M; Solari D; Pagliuca F; Villa A; Guadagno E; Cavallo LM; Colao A; Pettinato G; Cappabianca P
    Neurosurg Rev; 2017 Jan; 40(1):105-114. PubMed ID: 27215912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis.
    Chiloiro S; Doglietto F; Trapasso B; Iacovazzo D; Giampietro A; Di Nardo F; de Waure C; Lauriola L; Mangiola A; Anile C; Maira G; De Marinis L; Bianchi A
    Neuroendocrinology; 2015; 101(2):143-50. PubMed ID: 25633744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prognostic Roles of the Ki-67 Proliferation Index, P53 Expression, Mitotic Index, and Radiological Tumor Invasion in Pituitary Adenomas.
    Hasanov R; Aydoğan Bİ; Kiremitçi S; Erden E; Güllü S
    Endocr Pathol; 2019 Mar; 30(1):49-55. PubMed ID: 30610566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of High Prolactin Level on Postoperative Day 1 and Tumor Invasion with Female Gonadal Dysfunction After Trans-Sphenoidal Surgery of Pituitary Adenomas.
    Huang X; Zhang R; Wu Y; Sheng L; Xu J; Zha B; Liu J
    Med Sci Monit; 2018 Dec; 24():9265-9271. PubMed ID: 30569911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of pituitary adenomas.
    Chanson P; Salenave S
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic approach for giant pituitary adenoma: clinical outcomes of 205 patients and comparison of two proposed classification systems for preoperative prediction of extent of resection.
    Ceylan S; Sen HE; Ozsoy B; Ceylan EC; Ergen A; Selek A; Anik Y; Balci S; Cabuk B; Anik I
    J Neurosurg; 2022 Mar; 136(3):786-800. PubMed ID: 34534953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic Endonasal Approach to Giant Pituitary Adenomas: Surgical Outcomes and Review of the Literature.
    Rahimli T; Hidayetov T; Yusifli Z; Memmedzade H; Rajabov T; Aghayev K
    World Neurosurg; 2021 May; 149():e1043-e1055. PubMed ID: 33524611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Cavernous Sinus Extension and MRI T2 Hypointensity in the Extent of Resection following Trans-Sphenoidal Surgery for Giant Pituitary Adenomas.
    Singla R; Sharma R; Suri A
    Neurol India; 2023; 71(5):907-915. PubMed ID: 37929426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.